Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Liver Diseases

Free Subscription 18.08.2025 3 Biochem Biophys Res Commun 3 BMC Cancer 5 BMC Gastroenterol 1 Br J Surg 1 Cancer Res 4 Dig Dis Sci 2 Endoscopy 2 Gut 2 Hepatology 2 Int J Cancer 2 J Hepatol 2 Oncogene 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biochem Biophys Res Commun

1. SHARMA I, Singh VK, Vyas R, Verma M, et al
   Computational insights into CHST11 and CHST13: homology modeling, molecular docking, and dynamics simulation for novel therapeutic targeting in cancers.
   Biochem Biophys Res Commun. 2025;777:152323.
   PubMed         Abstract available
   
   
2. YU CHJ, Rupasinghe HPV
   Elucidating the mechanistic interplay of AMPK and Nrf2 in MASLD: A focus on dietary phytochemical modulation of lipid and redox homeostasis.
   Biochem Biophys Res Commun. 2025;777:152300.
   PubMed         Abstract available
   
   
3. XIANG Y, Liang M, Feng M, Peng Y, et al
   Biosafety of hyperbranched polylysine and its regulatory effect on non-alcoholic fatty liver and gut microbiota.
   Biochem Biophys Res Commun. 2025;777:152253.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. SUI WF, Duan YX, Cai ZF, Xia YM, et al
   Adverse drug reaction to tremelimumab and durvalumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system database.
   BMC Cancer. 2025;25:1289.
   PubMed         Abstract available
   
   
5. ELWALI NE, AlShareef SM, Khamis AH, Elhassan MMA, et al
   Liver cancer incidence in Saudi Arabia (2001-2020): decreasing trend.
   BMC Cancer. 2025;25:1284.
   PubMed         Abstract available
   
   
6. YU P, Li J, Feng W, Lei T, et al
   SKP2 ubiquitylation modifies IDH1 to regulate hepatoblastoma cell cycle and glucose metabolism.
   BMC Cancer. 2025;25:1304.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

7. LI R, Huang Z, Liu Y, Li T, et al
   Efficacy of prophylactic dexamethasone in reducing post-embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis.
   BMC Gastroenterol. 2025;25:577.
   PubMed         Abstract available
   
   
8. LI PC, Chen CC
   Features on contrast-enhanced computed tomography for predicting recurrent esophageal variceal bleeding in patients with hepatocellular carcinoma.
   BMC Gastroenterol. 2025;25:573.
   PubMed         Abstract available
   
   
9. KOKY T, Drazilova S, Janicko M, Toporcerova D, et al
   Early assessment of treatment response in primary biliary cholangitis: key to timely management.
   BMC Gastroenterol. 2025;25:571.
   PubMed         Abstract available
   
   
10. WANG N, Wu Y, Xiao M, Jie Y, et al
    Dynamic changes in liver stiffness measurement by 2D shear-wave elastography predict hepatocellular carcinoma in patients with chronic hepatitis B and well-controlled viremia: a retrospective study.
    BMC Gastroenterol. 2025;25:578.
    PubMed         Abstract available
    
    
11. JI Q, Shi C, Gu X, Yang L, et al
    Elucidating the role of AC026412.3 in hepatocellular carcinoma: a prognostic disulfidptosis-related LncRNAs model perspective.
    BMC Gastroenterol. 2025;25:579.
    PubMed         Abstract available
    
    

    
    Br J Surg

12. HUIBERS A, Wong A, Burgmans M, Ny L, et al
    Management of liver metastases from uveal melanoma.
    Br J Surg. 2025;112:znaf130.
    PubMed         Abstract available
    
    

    
    Cancer Res

13. CHEN K, Feng H, Zhang Y, Pei J, et al
    Tumor-derived CCL16 Normalizes Tumor Vasculature through Macrophage ICAM-1 Receptor and Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma.
    Cancer Res. 2025 Aug 12. doi: 10.1158/0008-5472.CAN-24-4323.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

14. TAMBAKI M, Neonaki A, Lekakis V, Papatheodoridi M, et al
    Monitoring Liver and Spleen Stiffness Changes May Predict Clinical Response to Non-selective B-Blockers in Portal Hypertension: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2025 Aug 9. doi: 10.1007/s10620-025-09304.
    PubMed         Abstract available
    
    
15. ABATE HM, Bujnowski D, Jowell A, Moylan CA, et al
    Ubiquitous Environmental Exposures and Risk of Hepatocellular Carcinoma: A Narrative Review.
    Dig Dis Sci. 2025 Aug 10. doi: 10.1007/s10620-025-09212.
    PubMed         Abstract available
    
    
16. NIU J, Wu W, Zhang H, Li Z, et al
    Aflatoxin B1 Promotes M2-like Macrophage Polarization via IL-6 Expression in Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Aug 11. doi: 10.1007/s10620-025-09230.
    PubMed         Abstract available
    
    
17. WEI R, Wang X, Zhao X, Zhang W, et al
    An Unusual Cause of Treatable Portal Hypertension.
    Dig Dis Sci. 2025 Aug 13. doi: 10.1007/s10620-025-09330.
    PubMed        
    
    

    
    Endoscopy

18. NIE X, Li Y, Liu Y, Hu C, et al
    Endoscopic titanium clip with nylon loop for treating esophageal and gastric variceal bleeding after endoscopic variceal ligation and transjugular intrahepatic portosystemic shunt.
    Endoscopy. 2025;57.
    PubMed        
    
    
19. KITAGAWA S, Murakoshi N, Okamura K
    The "garden eel" technique for endoscopic treatment of hepatolithiasis beyond multiple acutely angled sections with strictures.
    Endoscopy. 2025;57.
    PubMed        
    
    

    
    Gut

20. LUCAS-RUIZ F, Vidal-Correoso D, Mateo SV, de la Torre-Alamo MM, et al
    Intrahepatic donor microbiota-based metataxonomic signature detected in organ preservation solution enables prediction of short-term liver transplant outcomes.
    Gut. 2025 Aug 12:gutjnl-2025-335986. doi: 10.1136/gutjnl-2025-335986.
    PubMed         Abstract available
    
    
21. WU X, Quan D, Li W, Wisskirchen K, et al
    Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial.
    Gut. 2025 Aug 12:gutjnl-2025-335456. doi: 10.1136/gutjnl-2025-335456.
    PubMed         Abstract available
    
    

    
    Hepatology

22. ZHOU SL, Yin D, Hu ZQ, Luo CB, et al
    Erratum: A positive feedback loop between cancer stem-like cells and tumor-associated neutrophils controls hepatocellular carcinoma progression.
    Hepatology. 2025 Aug 14. doi: 10.1097/HEP.0000000000001476.
    PubMed        
    
    
23. JOHN BV, Bastaich DR, Deng Y, Singal AG, et al
    Use of liver stiffness measurement for hepatocellular carcinoma risk stratification in metabolic dysfunction associated steatotic liver disease.
    Hepatology. 2025 Aug 14. doi: 10.1097/HEP.0000000000001498.
    PubMed         Abstract available
    
    

    
    Int J Cancer

24. PASSEN CV, Krug J, Weiss L, Abdou MM, et al
    Integrin beta6 expression in colorectal cancer cells promotes liver metastasis through enhanced adhesion to endothelial fibronectin.
    Int J Cancer. 2025 Jun 9. doi: 10.1002/ijc.35504.
    PubMed         Abstract available
    
    
25. YANG Z, Wang L, Kang F
    Immunogenic cell death: A promising mechanism involving different therapeutic strategies for liver cancer.
    Int J Cancer. 2025;157:1267-1276.
    PubMed         Abstract available
    
    

    
    J Hepatol

26. VERMA N, Garg P, Kaur P, Munjal S, et al
    Identification and validation of RIPK3 as a novel biomarker to predict outcomes in patients with acutely decompensated cirrhosis.
    J Hepatol. 2025 Aug 12:S0168-8278(25)02405-5. doi: 10.1016/j.jhep.2025.
    PubMed         Abstract available
    
    
27. MEYER T, Finn RS, Borad M, Mahipal A, et al
    Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma.
    J Hepatol. 2025 Aug 12:S0168-8278(25)02404-3. doi: 10.1016/j.jhep.2025.
    PubMed         Abstract available
    
    

    
    Oncogene

28. ZHAO J, Cui M, Yao X, Jiang Z, et al
    Targeting TFAM downregulation mediated mtDNA-NLRP3 pathway suppresses TAM infiltration and HCC progression.
    Oncogene. 2025;44:2956-2969.
    PubMed         Abstract available
    
    
29. HAN J, Wang F, Lan Y, Wang J, et al
    Retraction Note to: KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.
    Oncogene. 2025 Aug 11. doi: 10.1038/s41388-025-03527.
    PubMed        
    
    

    
    Transplant Proc

30. KIM J, Hong SK, Lee A, Kumar SN, et al
    Activity-Dependent Effects of ERK1/2 on Hepatic Ischemia-Reperfusion Injury.
    Transplant Proc. 2025 Aug 11:S0041-1345(25)00350.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.